BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19680621)

  • 1. [Informed consent for patients on early recognition of prostate carcinoma is insufficient].
    Börgermann C; vom Dorp F; Rossi R; Schenck M; Luboldt HJ; Rübben H
    Urologe A; 2009 Sep; 48(9):997-8, 1000-1. PubMed ID: 19680621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of Sweden.
    Fridriksson J; Gunseus K; Stattin P
    Scand J Urol Nephrol; 2012 Oct; 46(5):326-31. PubMed ID: 22647143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
    Molazem Z; Ebadi M; Khademian M; Zare R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPs views and understanding of PSA testing, screening and early detection; survey.
    Sutton J; Melia J; Kirby M; Graffy J; Moss S
    Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?
    Chan EC; Vernon SW; O'Donnell FT; Ahn C; Greisinger A; Aga DW
    Am J Public Health; 2003 May; 93(5):779-85. PubMed ID: 12721144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites.
    Chan EC; Vernon SW; Ahn C; Greisinger A
    Am J Public Health; 2004 Aug; 94(8):1336-8. PubMed ID: 15284039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of informed consent on patient interest in prostate-specific antigen screening.
    Wolf AM; Nasser JF; Wolf AM; Schorling JB
    Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer knowledge in Irish men.
    Casey RG; Rea DJ; McDermott T; Grainger R; Butler M; Thornhill JA
    J Cancer Educ; 2012 Mar; 27(1):120-31. PubMed ID: 21808998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PSA-screening for prostate cancer--yes or no?].
    Recker F; Kwiatkowski M
    Ther Umsch; 2004 Jun; 61(6):353-8. PubMed ID: 15253159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed consent for PSA testing.
    Brown V
    J Fam Pract; 1996 Sep; 43(3):234-5. PubMed ID: 8797747
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial panel on informed consent for PSA screening.
    Ramsden AR; Chodak G
    Urology; 2003 Sep; 62(3):589. PubMed ID: 12946782
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploring the complexities of prostate cancer screening with a view to supporting informed consent.
    Laws TA
    Contemp Nurse; 2004 Oct; 17(3):223-30. PubMed ID: 15551673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting informed decision making online in 20 minutes: an observational web-log study of a PSA test decision aid.
    Joseph-Williams N; Evans R; Edwards A; Newcombe RG; Wright P; Grol R; Elwyn G
    J Med Internet Res; 2010 May; 12(2):e15. PubMed ID: 20507844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.